Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment

Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment

US Patent 7070945 · Granted Jul 4, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP2021
Nanoformulations containing encapsulted omega-3 fatty acids2021
Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP2016
Process and composition for stabilization of vulnerable plaque utilizing a combi2016
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid2015
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels2015
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of ch2015
Method for treating obesity with anti-obesity formulations and omega 3 fatty aci2014
Diagnostic methods for congestive heart failure2012
Method for diagnosing and distinguishing stroke and diagnostic devices for use t2011
Calibrator for NT-proBNP immunoassay2010
Method for diagnosing and distinguishing stroke and diagnostic devices for use t2010